Safety and effectiveness of metformin plus lifestyle intervention compared with lifestyle intervention alone in preventing progression to diabetes in a Chinese population with impaired glucose regulation: a multicentre, open-label, randomised controlled trial

Lihui Zhang(Hebei Medical University), Shuang Yan(Cancer Institute (WIA)), Sheng'ai Shen(Yanbian University Hospital), Zhixia Yang(Mudanjiang Medical University), Luling Dong(Kailuan General Hospital), Qiang Lü(First Affiliated Hospital of Jiangxi Medical College), Fang Hou, Guangwei Li(Hebei Medical University), Lin Qi(Jilin Medical University), Yufeng Li(Nanjing Medical University), Ningling Sun(Peking University People's Hospital), Yanjie Liu(Harbin Medical University), Jianling Du(First Affiliated Hospital of Dalian Medical University), Lian Xu(Dalian Medical University), Qiuyun Li(Tumor Hospital of Guangxi Medical University), Weidong Ren(Hebei North University), Wenli Cheng(Beijing Anzhen Hospital), Dong‐Hong Wu(The First Hospital of Kunming), Qiuhong Gong(Harbin Medical University)
The Lancet Diabetes & Endocrinology
July 3, 2023
Cited by 83


Related Papers